C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. Income Statement 2021–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 35.9M | 35.6M | 20.8M | 31.1M | 45.8M |
| Gross Profit | — | — | — | — | — |
| Profitability | |||||
| Operating Income | -115.2M | -119.6M | -139.0M | -129.5M | -82.1M |
| EBITDA | -113.3M | -117.8M | -137.2M | -127.9M | -80.6M |
| Net Income | -105.0M | -105.3M | -132.5M | -128.2M | -83.9M |
| Per Share Data | |||||
| EPS (diluted) | — | — | — | — | — |
| Shares Outstanding (dil.) | 83M | 69M | 50M | 49M | 46M |
C4 Therapeutics Inc. Income Statement — FAQ
C4 Therapeutics Inc. (CCCC) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's income statement history?
The chart and table above show C4 Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.